|
A Vitamin
D compound given before low-dose radiation to treat breast cancer
may help kill malignant cells without damaging healthy tissue,
according to researchers at Virginia Commonwealth University Medical
Center.
The researchers
used breast cancer cell cultures to test the effect of a modified
form of Vitamin D called ILX 23-7553 alone and in combination
with low doses of ionizing radiation. By pre-treating cells with
the Vitamin D compound before radiation, the found the number
of cancer cells after irradiation was almost 30 percent lower
than using radiation alone.
The study,
to be published in Cancer Chemotherapy and Pharmacology, also
found that combining the Vitamin D compound and low-dose radiation
resulted in continued death of breast cancer cells for a week
after treatment and might inhibit recurrence.
"Our
study shows that pre-treatment of breast tumor cells with a Vitamin
D analog significantly enhanced the effectiveness of the irradiation
treatment," reported David A. Gewirtz, a professor of pharmacology
and toxicology.
Results of
the study, if confirmed in human trials, could ultimately lead
to shorter radiation treatment periods for breast cancer patients.
Other
sources: Virginia Commonwealth University
|